1. Home
  2. GSIT vs CTMX Comparison

GSIT vs CTMX Comparison

Compare GSIT & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSIT
  • CTMX
  • Stock Information
  • Founded
  • GSIT 1995
  • CTMX 2008
  • Country
  • GSIT United States
  • CTMX United States
  • Employees
  • GSIT N/A
  • CTMX N/A
  • Industry
  • GSIT Semiconductors
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GSIT Technology
  • CTMX Health Care
  • Exchange
  • GSIT Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • GSIT 82.4M
  • CTMX 444.3M
  • IPO Year
  • GSIT N/A
  • CTMX 2015
  • Fundamental
  • Price
  • GSIT $3.35
  • CTMX $2.27
  • Analyst Decision
  • GSIT
  • CTMX Strong Buy
  • Analyst Count
  • GSIT 0
  • CTMX 2
  • Target Price
  • GSIT N/A
  • CTMX $5.00
  • AVG Volume (30 Days)
  • GSIT 261.7K
  • CTMX 2.7M
  • Earning Date
  • GSIT 07-24-2025
  • CTMX 08-07-2025
  • Dividend Yield
  • GSIT N/A
  • CTMX N/A
  • EPS Growth
  • GSIT N/A
  • CTMX 128.27
  • EPS
  • GSIT N/A
  • CTMX 0.49
  • Revenue
  • GSIT $20,518,000.00
  • CTMX $147,557,000.00
  • Revenue This Year
  • GSIT N/A
  • CTMX N/A
  • Revenue Next Year
  • GSIT N/A
  • CTMX N/A
  • P/E Ratio
  • GSIT N/A
  • CTMX $4.78
  • Revenue Growth
  • GSIT N/A
  • CTMX 23.81
  • 52 Week Low
  • GSIT $1.62
  • CTMX $0.40
  • 52 Week High
  • GSIT $4.90
  • CTMX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • GSIT 58.51
  • CTMX 50.77
  • Support Level
  • GSIT $3.30
  • CTMX $2.08
  • Resistance Level
  • GSIT $3.44
  • CTMX $2.44
  • Average True Range (ATR)
  • GSIT 0.16
  • CTMX 0.24
  • MACD
  • GSIT 0.02
  • CTMX -0.08
  • Stochastic Oscillator
  • GSIT 74.24
  • CTMX 19.12

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: